secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALISADE BIO, INC. (PALI)
CIK:        0001357459
Form:       8-K
Filed at:   2024-12-16T23:59:59+00:00
Accession:  0001493152-24-050203
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud

Palisade Bio Closes $5M Underwritten Public Offering of Units and Warrants
--------------------------------------------------------------------------

- Issued 158,000 Class A Units (common + warrant) and 3,120,688 Class B Units (prefunded warrant + warrant) at $1.525/$1.5249 per unit.
- Gross proceeds $5 million; net proceeds approximately $4.1 million after underwriting discounts and expenses.
- Proceeds to fund Phase 1 trial of PALI-2108, pre-clinical studies, R&D, and working capital.
- Repriced approximately 1,040,217 previously issued warrants to $1.40 per share for participating investor.
- Underwriter Ladenburg Thalmann & Co. Inc.; 45-day overallotment option for up to 491,803 additional shares/warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357459/000149315224050203/0001493152-24-050203-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357459/000149315224050203/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-050203

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer